Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.

Conditions

• Parkinson Disease

Interventions

• BEHAVIORAL: Assessment of severity of ICD (impulse control disorders)
• BEHAVIORAL: Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors
• BEHAVIORAL: Assessment of quality of life
• BEHAVIORAL: Assessment of depression
• BEHAVIORAL: Assessment of cognition
• BEHAVIORAL: Assessment of severity of Parkinson Disease
• PROCEDURE: Cardiac monitoring

Sponsor

University Hospital, Strasbourg, France

Collaborators

• [object Object]
• [object Object]
• [object Object]